BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38409573)

  • 1. Nirogacestat: First Approval.
    Keam SJ
    Drugs; 2024 Mar; 84(3):355-361. PubMed ID: 38409573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
    Gounder M; Ratan R; Alcindor T; Schöffski P; van der Graaf WT; Wilky BA; Riedel RF; Lim A; Smith LM; Moody S; Attia S; Chawla S; D'Amato G; Federman N; Merriam P; Van Tine BA; Vincenzi B; Benson C; Bui NQ; Chugh R; Tinoco G; Charlson J; Dileo P; Hartner L; Lapeire L; Mazzeo F; Palmerini E; Reichardt P; Stacchiotti S; Bailey HH; Burgess MA; Cote GM; Davis LE; Deshpande H; Gelderblom H; Grignani G; Loggers E; Philip T; Pressey JG; Kummar S; Kasper B
    N Engl J Med; 2023 Mar; 388(10):898-912. PubMed ID: 36884323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.
    Takahashi T; Prensner JR; Robson CD; Janeway KA; Weigel BJ
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28636. PubMed ID: 32762028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Secretase directly sheds the survival receptor BCMA from plasma cells.
    Laurent SA; Hoffmann FS; Kuhn PH; Cheng Q; Chu Y; Schmidt-Supprian M; Hauck SM; Schuh E; Krumbholz M; Rübsamen H; Wanngren J; Khademi M; Olsson T; Alexander T; Hiepe F; Pfister HW; Weber F; Jenne D; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
    Nat Commun; 2015 Jun; 6():7333. PubMed ID: 26065893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New, tolerable γ-secretase inhibitor takes desmoid down a notch.
    Hughes DP; Kummar S; Lazar AJ
    Clin Cancer Res; 2015 Jan; 21(1):7-9. PubMed ID: 25336699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
    Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
    J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.
    Villalobos VM; Hall F; Jimeno A; Gore L; Kern K; Cesari R; Huang B; Schowinsky JT; Blatchford PJ; Hoffner B; Elias A; Messersmith W
    Ann Surg Oncol; 2018 Mar; 25(3):768-775. PubMed ID: 28887726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design.
    Wei P; Walls M; Qiu M; Ding R; Denlinger RH; Wong A; Tsaparikos K; Jani JP; Hosea N; Sands M; Randolph S; Smeal T
    Mol Cancer Ther; 2010 Jun; 9(6):1618-28. PubMed ID: 20530712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nirogacestat effective in desmoid tumours.
    Sidaway P
    Nat Rev Clin Oncol; 2023 May; 20(5):284. PubMed ID: 36997640
    [No Abstract]   [Full Text] [Related]  

  • 10. Single Site
    Huang HW; Chen CC; Lin KI; Hsu TL; Wong CH
    ACS Chem Biol; 2024 Jan; 19(1):153-161. PubMed ID: 38085681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Notch signaling pathway in desmoid tumor: Recent advances and the therapeutic prospects.
    Zheng C; Huang J; Xu G; Li W; Weng X; Zhang S
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166907. PubMed ID: 37793461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
    Pont MJ; Hill T; Cole GO; Abbott JJ; Kelliher J; Salter AI; Hudecek M; Comstock ML; Rajan A; Patel BKR; Voutsinas JM; Wu Q; Liu L; Cowan AJ; Wood BL; Green DJ; Riddell SR
    Blood; 2019 Nov; 134(19):1585-1597. PubMed ID: 31558469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myeloma.
    Cowan AJ; Green DJ
    Br J Haematol; 2024 Feb; 204(2):391-392. PubMed ID: 38014717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases.
    Chan D; Kaplan J; Gordon G; Desai J
    Curr Oncol; 2021 Sep; 28(5):3659-3667. PubMed ID: 34590610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management and recent progress in desmoid tumors.
    Zhou MY; Bui NQ; Charville GW; Ghanouni P; Ganjoo KN
    Cancer Treat Res Commun; 2022; 31():100562. PubMed ID: 35460976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer's disease treatment by inhibition/modulation of the gamma-secretase activity].
    Tomita T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):845-7. PubMed ID: 20030227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
    Cowan AJ; Pont MJ; Sather BD; Turtle CJ; Till BG; Libby EN; Coffey DG; Tuazon SA; Wood B; Gooley T; Wu VQ; Voutsinas J; Song X; Shadman M; Gauthier J; Chapuis AG; Milano F; Maloney DG; Riddell SR; Green DJ
    Lancet Oncol; 2023 Jul; 24(7):811-822. PubMed ID: 37414012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verteporfin is a substrate-selective γ-secretase inhibitor that binds the amyloid precursor protein transmembrane domain.
    Castro MA; Parson KF; Beg I; Wilkinson MC; Nurmakova K; Levesque I; Voehler MW; Wolfe MS; Ruotolo BT; Sanders CR
    J Biol Chem; 2022 Apr; 298(4):101792. PubMed ID: 35247387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.
    Chen X; Chen X; Zhou Z; Mao Y; Wang Y; Ma Z; Xu W; Qin A; Zhang S
    Exp Cell Res; 2019 Sep; 382(1):111470. PubMed ID: 31211955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic defects of gamma-secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case report.
    Cattaneo I; Valgardsdottir R; Cavagna R; Spinelli O; Bartoletti-Stella A; Capellari S; Galli M; Golay J
    Br J Haematol; 2024 Feb; 204(2):571-575. PubMed ID: 37957838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.